UpdatesPress Release
Dishman Carbogen Amcis Q3 consolidated net revenue rose 5.5% to ₹719.8 Cr, driven by CDMO.
Dishman Carbogen Amcis LimitedDCAL · Filed with the exchange
Q3 EBITDA fell to ₹113.1 Cr (15.7% margin) due to lower late Phase III molecules.
9M revenue grew 4.3% to ₹2080.5 Cr, with 9M EBITDA up at ₹402.7 Cr (19.4% margin).
No comments yet. Be the first.